US 8,124,799 · Application 12/426,778 · Granted Feb 28, 2012
US 8,124,799
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
Estimated expiration
April 14, 2030
3y 189d remaining
Earliest effective filing
Apr 20, 2009
+ 20 years
Apr 20, 2029
PTA +359d
Apr 14, 2030
No TD
—
Final
Apr 14, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- April 20, 2009
- Earliest effective filing
- April 20, 2009
- Issue date
- February 28, 2012
- PTA
- +359 days
- Base expiry (before PTA)
- April 20, 2029
April 20, 2009 + 20 years = April 20, 2029 + 359 PTA days = April 14, 2030
- PRO61/046,342 — Provisional — not used for base term
- PRO61/111,269 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/426,778 · US 8,124,799
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,124,799: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8124799Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.